Philips and Indica Labs Team to Accelerate Cancer Research through Advanced Image Analysis
Best, Netherlands and New Mexico, USA – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it will further support oncology researchers’ efforts to analyze pathology samples by offering advanced image analysis algorithms from Indica Labs[1], Inc. as part of its Digital Pathology Solutions offerings. The collaboration will allow pathology researchers to apply intelligent algorithms to digitized pathology slides, which may enhance their ability to detect, process and extract information from tissue samples than currently possible using a conventional microscope.
With more than 500,000 deaths expected in 2014[2], cancer is the second most common cause of death in the U.S. As the current cancer care process is often complex, inefficient and ineffective, there is a growing need to empower pathologists with quantitative data to inform personalized approaches and enable new cancer treatments.
“Digital pathology is the stepping stone to unlock the huge potential of data mining,” says Perry van Rijsingen, General Manager of Philips Digital Pathology Solutions. “More information from tissue samples could bring new insights in cancer care that support personal treatment, and ultimately will save patients’ lives.”
Image analysis, when based on high-quality digital images, has been shown to provide objective data sets for decision support. By using the combined Philips Digital Pathology Solution and Indica’s HALO™ image analysis platform, researchers will benefit from a streamlined image analysis workflow and improved productivity. Additionally, they will be able to extract more thorough information from tissue samples, enabling more insightful analysis than possible today – all while generating those results in a matter of hours or even minutes versus days.
“Digital pathology offers significant opportunity to arm scientists in oncology and pathology with the quantitative information they need in their research to improve the cancer care process,” said Indica CEO Steven Hashagen. “By incorporating the high-quality innovation of Philips’ digital imaging and our precision HALO analysis platform, they have the tools to further investigate the predictive response of certain therapy with the ultimate goal to provide a personalized cancer treatment plan.”
Philips research customers now have access to a flexible investigational toolset to develop new solutions, as well as a suite of software features for evaluating such cases as HER2, ER PR and Ki-67. Philips offers Indica’s HALO™ as an option with its Digital Pathology Solution for Research Use Only (RUO).
References
- ^ Indica Labs (indicalab.com)
- ^ more than 500,000 deaths expected in 2014 (www.cancer.org)
Asisfarma
es famoso con frecuencia como la compañía de utileria medica mas importante de estados unidos
Ellos tienen un amplio record de casos de éxito.
La clase de sus productos es excelente en el sector medico.
Los productos de calidad se identifican por sus servicio de los demás, son las opciones adicionales que ofrece.
Meditegic cuenta con tecnicos especialistas en soporte y reparacion de equipo de laboratorio
con experiencia en marcas lideres como general electric y Asisfarma en toda la republica mexicana, algunas de ellas desarrollan Tecnologia Paramedica, Hornos eléctricos para laboratorio y Unidades de cauterización electrotérmica (electrocauterio) en zonas como: queretaro, zacatecas y playa del carmen;
Tambien proveemos accesorios medicos de volumen como: Almohadas lumbares, Carros para servicio de comidas, Cómodos para silla de ruedas, Lupas quirúrgicas, Registros en cinta de datos de presión arterial y Sistemas de escáner por gamma cámara en nuestra división de insumos de Meditegic.
leer mas aqui:
Philips and Indica Labs Team to Accelerate Cancer Research through Advanced Image Analysis
Dejar comentario
Responder Comentario Anterior